Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
JD Lünemann, 2009, EBV in MS: guilty by association?, Trends Immunol, 30, 243, 10.1016/j.it.2009.03.007
A Ascherio, 2010, Epstein-Barr virus infection and multiple sclerosis: a review, J Neuroimmune Pharmacol, 5, 271, 10.1007/s11481-010-9201-3
MP Pender, 2011, The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis, Neuroscientist, 17, 351, 10.1177/1073858410381531
DA Thorley-Lawson, 2001, Epstein-Barr virus: exploiting the immune system, Nat Rev Immunol, 1, 75, 10.1038/35095584
DN Posnett, 2008, Herpesviruses and autoimmunity, Curr Opin Investig Drugs, 9, 505
CV Sumaya, 1985, Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis, Ann Neurol, 17, 371, 10.1002/ana.410170412
P Sundström, 2004, An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study, Neurology, 62, 2277, 10.1212/01.WNL.0000130496.51156.D7
LI Levin, 2005, Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis, JAMA, 293, 2496, 10.1001/jama.293.20.2496
B Banwell, 2007, Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study, Lancet Neurol, 6, 773, 10.1016/S1474-4422(07)70196-5
JD Lünemann, 2008, Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis, Neurology, 71, 1033, 10.1212/01.wnl.0000326576.91097.87
R Mechelli, 2011, Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins, Mult Scler, 17, 1290, 10.1177/1352458511410515
A Ascherio, 2001, Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study, JAMA, 286, 3083, 10.1001/jama.286.24.3083
JD Lünemann, 2010, Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis, Ann Neurol, 67, 159, 10.1002/ana.21886
AE Handel, 2010, an updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis, PLoS One, 5, e12496, 10.1371/journal.pone.0012496
JD Lünemann, 2006, Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis, Brain, 129, 1493, 10.1093/brain/awl067
P Höllsberg, 2003, Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis, Clin Exp Immunol, 132, 137, 10.1046/j.1365-2249.2003.02114.x
S Cepok, 2005, Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis, J Clin Invest, 115, 1352, 10.1172/JCI200523661
S Jilek, 2008, Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis, Brain, 131, 1712, 10.1093/brain/awn108
MP Pender, 2009, Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis, J Neurol Neurosurg Psychiatry, 80, 498, 10.1136/jnnp.2008.161018
S Jilek, 2012, HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis, J Immunol, 188, 4671, 10.4049/jimmunol.1103100
MP Pender, 2003, Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases, Trends Immunol, 24, 584, 10.1016/j.it.2003.09.005
JD Lünemann, 2008, EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2, J Exp Med, 205, 1763, 10.1084/jem.20072397
HL Lang, 2002, A functional and structural basis for TCR cross-reactivity in multiple sclerosis, Nat Immunol, 3, 940, 10.1038/ni835
H Lassmann, 2011, Epstein-Barr virus in the multiple sclerosis brain: a controversial issue - report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria, Brain, 134, 2772, 10.1093/brain/awr197
LA Peferoen, 2010, Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis, Brain, 133, 1, 10.1093/brain/awp296
SN Willis, 2009, Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain, Brain, 132, 3318, 10.1093/brain/awp200
O Torkildsen, 2010, Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients, Brain Pathol, 20, 720, 10.1111/j.1750-3639.2009.00343.x
SA Sargsyan, 2010, Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis, Neurology, 74, 1127, 10.1212/WNL.0b013e3181d865a1
B Serafini, 2007, Dysregulated Epstein Barr virus infection in the multiple sclerosis brain, J Exp Med, 204, 2899, 10.1084/jem.20071030
B Serafini, 2010, Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation, J Neuropathol Exp Neurol, 69, 677, 10.1097/NEN.0b013e3181e332ec
B Serafini, 2013, Radioactive in situ hybridization for EBER supports presence of Epstein-Barr virus in the multiple sclerosis brain, Brain
JS Tzartos, 2012, Association of innate immune activation with latent Epstein-Barr virus in active MS lesions, Neurology, 78, 15, 10.1212/WNL.0b013e31823ed057
RA Farrell, 2009, Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI, Neurology, 73, 32, 10.1212/WNL.0b013e3181aa29fe
D Buljevac, 2005, Epstein-Barr virus and disease activity in multiple sclerosis, J Neurol Neurosurg Psychiatry, 76, 1377, 10.1136/jnnp.2004.048504
RJ Murray, 1992, Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies, J Exp Med, 176, 157, 10.1084/jem.176.1.157
NM Steven, 1997, Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response, J Exp Med, 185, 1605, 10.1084/jem.185.9.1605
U Palendira, 2008, Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow, Blood, 112, 3293, 10.1182/blood-2008-02-138040
BC Kieseier, 2011, The mechanism of action of interferon-β in relapsing multiple sclerosis, CNS Drugs, 25, 491, 10.2165/11591110-000000000-00000
R Rudick, 2012, Natalizumab: Bench to Bedside and Beyond, Arch Neurol, 5, 1
LL Laichalk, 2005, Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo, J Virol, 79, 1296, 10.1128/JVI.79.2.1296-1307.2005
A Farina, 2000, The BFRF1 gene of Epstein-Barr virus encodes a novel protein, J Virol, 74, 3235, 10.1128/JVI.74.7.3235-3244.2000
AD Hislop, 2007, Cellular responses to viral infection in humans: lessons from Epstein-Barr virus, Annu Rev Immunol, 25, 587, 10.1146/annurev.immunol.25.022106.141553
EJ Wherry, 2007, Molecular signature of CD8+ T cell exhaustion during chronic viral infection, Immunity, 27, 670, 10.1016/j.immuni.2007.09.006
D Sauce, 2009, Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection, J Virol, 83, 9068, 10.1128/JVI.00141-09
AJ Gross, 2005, EBV and systemic lupus erythematosus: a new perspective, J Immunol, 174, 6599, 10.4049/jimmunol.174.11.6599
M Larsen, 2011, Exhausted cytotoxic control of Epstein-Barr virus in human lupus, PLoS Pathog, 7, e1002328, 10.1371/journal.ppat.1002328
M Comabella, 2012, EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy, Mult Scler J, 18, 605, 10.1177/1352458511426816
G Frisullo, 2011, CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment, Mult Scler, 17, 556, 10.1177/1352458510392263
Means RE, Lang SM, Jung JU. (2007) Human gammaherpesvirus immune evasion strategies. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press. Chapter 31.
E Jaquiéry, 2010, Intrathecal immune responses to EBV in early MS, Eur J Immunol, 40, 878, 10.1002/eji.200939761
C Malmeström, 2008, Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF, J Neuroimmunol, 196, 159, 10.1016/j.jneuroim.2008.03.001
H Babbe, 2000, Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction, J Exp Med, 192, 393, 10.1084/jem.192.3.393
C Skulina, 2004, Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood, Proc Natl Acad Sci U S A, 101, 2428, 10.1073/pnas.0308689100
EF Foxman, 2011, Genome-virome interactions: examining the role of common viral infections in complex disease, Nature Rev Microbiol, 9, 254, 10.1038/nrmicro2541
M Recher, 2007, Extralymphatic virus sanctuaries as a consequence of potent T-cell activation, Nat Med, 13, 1316, 10.1038/nm1670
J Lycke, 1996, Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study, J Neurol, 243, 214, 10.1007/BF00868517
E Bech, 2002, A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS, Neurology, 58, 31, 10.1212/WNL.58.1.31
DH Dreyfus, 2011, Autoimmune disease: A role for new anti-viral therapies?, Autoimmun Rev, 11, 88, 10.1016/j.autrev.2011.08.005
CH Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, Ann Neurol, 58, 840, 10.1002/ana.20703
R Magliozzi, 2007, Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology, Brain, 130, 1089, 10.1093/brain/awm038
G Miller, 1973, Release of infectious Epstein-Barr virus by transformed marmoset leukocytes, Natl Acad Sci U S A, 70, 190, 10.1073/pnas.70.1.190